RATIONALE: Disrupted social behavior, including occasional aggressive outbursts, is characteristic of withdrawal from long-term alcohol (EtOH) use. Heavy EtOH use and exaggerated responses during withdrawal may be treated using glutamatergic N-methyl-D-aspartate receptor (NMDAR) antagonists. OBJECTIVES: The current experiments explore aggression and medial prefrontal cortex (mPFC) glutamate as consequences of withdrawal from intermittent access to EtOH and changes in aggression and mPFC glutamate caused by NMDAR antagonists memantine and ketamine. METHODS: Swiss male mice underwent withdrawal following 1-8 weeks of intermittent access to 20 % EtOH. Aggressive and nonaggressive behaviors with a conspecific were measured 6-8 h into EtOH withdrawal after memantine or ketamine (0-30 mg/kg, i.p.) administration. In separate mice, extracellular mPFC glutamate after memantine was measured during withdrawal using in vivo microdialysis. RESULTS: At 6-8 h withdrawal from EtOH, mice exhibited more convulsions and aggression and decreased social contact compared to age-matched water controls. Memantine, but not ketamine, increased withdrawal aggression at the 5-mg/kg dose in mice with a history of 8 weeks of EtOH but not 1 or 4 weeks of EtOH or in water drinkers. Tonic mPFC glutamate was higher during withdrawal after 8 weeks of EtOH compared to 1 week of EtOH or 8 weeks of water. Five milligrams per kilogram of memantine increased glutamate in 8-week EtOH mice, but also in 1-week EtOH and water drinkers. CONCLUSIONS: These studies reveal aggressive behavior as a novel symptom of EtOH withdrawal in outbred mice and confirm a role of NMDARs during withdrawal aggression and for disrupted social behavior.
RATIONALE: Disrupted social behavior, including occasional aggressive outbursts, is characteristic of withdrawal from long-term alcohol (EtOH) use. Heavy EtOH use and exaggerated responses during withdrawal may be treated using glutamatergic N-methyl-D-aspartate receptor (NMDAR) antagonists. OBJECTIVES: The current experiments explore aggression and medial prefrontal cortex (mPFC) glutamate as consequences of withdrawal from intermittent access to EtOH and changes in aggression and mPFCglutamate caused by NMDAR antagonists memantine and ketamine. METHODS: Swiss male mice underwent withdrawal following 1-8 weeks of intermittent access to 20 % EtOH. Aggressive and nonaggressive behaviors with a conspecific were measured 6-8 h into EtOH withdrawal after memantine or ketamine (0-30 mg/kg, i.p.) administration. In separate mice, extracellular mPFCglutamate after memantine was measured during withdrawal using in vivo microdialysis. RESULTS: At 6-8 h withdrawal from EtOH, mice exhibited more convulsions and aggression and decreased social contact compared to age-matched water controls. Memantine, but not ketamine, increased withdrawal aggression at the 5-mg/kg dose in mice with a history of 8 weeks of EtOH but not 1 or 4 weeks of EtOH or in water drinkers. Tonic mPFCglutamate was higher during withdrawal after 8 weeks of EtOH compared to 1 week of EtOH or 8 weeks of water. Five milligrams per kilogram of memantine increased glutamate in 8-week EtOHmice, but also in 1-week EtOH and water drinkers. CONCLUSIONS: These studies reveal aggressive behavior as a novel symptom of EtOH withdrawal in outbred mice and confirm a role of NMDARs during withdrawal aggression and for disrupted social behavior.
Authors: Jennifer L Winward; Nicole M Bekman; Karen L Hanson; Carl W Lejuez; Sandra A Brown Journal: Alcohol Clin Exp Res Date: 2014-05-12 Impact factor: 3.455
Authors: Zheng-Ming Ding; Zachary A Rodd; Eric A Engleman; Jason A Bailey; Debomoy K Lahiri; William J McBride Journal: Addict Biol Date: 2012-12-14 Impact factor: 4.280
Authors: Olivier George; Chelsea Sanders; John Freiling; Edward Grigoryan; Shayla Vu; Camryn D Allen; Elena Crawford; Chitra D Mandyam; George F Koob Journal: Proc Natl Acad Sci U S A Date: 2012-10-15 Impact factor: 11.205
Authors: Isabel M Quadros; Lara S Hwa; Akiko Shimamoto; Julia Carlson; Joseph F DeBold; Klaus A Miczek Journal: Neuropsychopharmacology Date: 2014-06-11 Impact factor: 7.853
Authors: Anna R Reynolds; Meredith A Saunders; Honoree' W Brewton; Sydney R Winchester; Ibrahim S Elgumati; Mark A Prendergast Journal: Drug Alcohol Depend Date: 2015-06-22 Impact factor: 4.492
Authors: Michael C Salling; Mary Jane Skelly; Elizabeth Avegno; Samantha Regan; Tamara Zeric; Elcoma Nichols; Neil L Harrison Journal: J Neurosci Date: 2018-06-18 Impact factor: 6.167
Authors: Klaus A Miczek; Joseph F DeBold; Lara S Hwa; Emily L Newman; Rosa M M de Almeida Journal: Ann N Y Acad Sci Date: 2015-08-18 Impact factor: 5.691
Authors: Emily L Newman; Miho Terunuma; Tiffany L Wang; Nishani Hewage; Matthew B Bicakci; Stephen J Moss; Joseph F DeBold; Klaus A Miczek Journal: Neuropsychopharmacology Date: 2017-10-20 Impact factor: 7.853